Ki Database: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
'''Ki Database''' is a comprehensive | == Ki Database == | ||
[[File:PDSPLogo.jpg|thumb|right|Logo of the Psychoactive Drug Screening Program]] | |||
The '''Ki Database''' is a comprehensive resource that provides information on the binding affinities of various ligands to a wide range of receptors, transporters, and ion channels. It is an essential tool for researchers in the fields of [[pharmacology]], [[neuroscience]], and [[drug discovery]]. The database is maintained by the [[Psychoactive Drug Screening Program]] (PDSP) at the [[University of North Carolina at Chapel Hill]]. | |||
== Overview == | == Overview == | ||
The Ki Database | The Ki Database contains data on the inhibitory constant, or Ki, which is a measure of how effectively a compound can inhibit a particular biological target. The lower the Ki value, the higher the affinity of the compound for the target. This information is crucial for understanding the potential efficacy and selectivity of drugs. | ||
== | == Data Collection == | ||
Data in the Ki Database is collected from a variety of sources, including published scientific literature and experimental results from the PDSP. The database is regularly updated to include new findings and to ensure the accuracy of the information provided. | |||
== | == Applications == | ||
The Ki Database is widely used in the development of new [[pharmaceuticals]]. By providing detailed information on the binding properties of compounds, researchers can identify promising drug candidates and optimize their chemical structures for better efficacy and safety. The database also aids in the study of [[receptor]] function and the development of [[therapeutic agents]] for various diseases. | |||
== | == Access and Usage == | ||
The Ki Database is | The Ki Database is accessible online and is freely available to the scientific community. Users can search for specific compounds or targets, and the database provides detailed reports on the binding affinities and related pharmacological data. | ||
== | == Related Pages == | ||
* [[Pharmacology]] | * [[Pharmacology]] | ||
* [[ | * [[Receptor (biochemistry)]] | ||
* [[ | * [[Drug discovery]] | ||
* [[ | * [[Neuroscience]] | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
[[Category: | [[Category:Databases]] | ||
[[Category: | [[Category:Neuroscience]] | ||
Latest revision as of 03:30, 13 February 2025
Ki Database[edit]

The Ki Database is a comprehensive resource that provides information on the binding affinities of various ligands to a wide range of receptors, transporters, and ion channels. It is an essential tool for researchers in the fields of pharmacology, neuroscience, and drug discovery. The database is maintained by the Psychoactive Drug Screening Program (PDSP) at the University of North Carolina at Chapel Hill.
Overview[edit]
The Ki Database contains data on the inhibitory constant, or Ki, which is a measure of how effectively a compound can inhibit a particular biological target. The lower the Ki value, the higher the affinity of the compound for the target. This information is crucial for understanding the potential efficacy and selectivity of drugs.
Data Collection[edit]
Data in the Ki Database is collected from a variety of sources, including published scientific literature and experimental results from the PDSP. The database is regularly updated to include new findings and to ensure the accuracy of the information provided.
Applications[edit]
The Ki Database is widely used in the development of new pharmaceuticals. By providing detailed information on the binding properties of compounds, researchers can identify promising drug candidates and optimize their chemical structures for better efficacy and safety. The database also aids in the study of receptor function and the development of therapeutic agents for various diseases.
Access and Usage[edit]
The Ki Database is accessible online and is freely available to the scientific community. Users can search for specific compounds or targets, and the database provides detailed reports on the binding affinities and related pharmacological data.